Zivo Bioscience
Business Services · Michigan, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
21 E Long Lake Rd Ste 100, Bloomfield Hi...Phone Number
(248) 452-9866Website
www.zivobioscience.comRevenue
<$5 MillionStock Symbol
ZIVOIndustry
About Zivo Bioscience
Zivo Bioscience Org Chart
Is Zivo Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Zivo Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Zivo Bioscience recently announced quarterly report
Check if Zivo Bioscience has recently received funding, and reach out quickly before it becomes old news!
Check out if Zivo Bioscience is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Zivo Bioscience
Product Launch: Get notified when Zivo Bioscience launches new products
Funding: Get notified immidiatlly once Zivo Bioscience has new funding data
Click to see if Zivo Bioscience had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Zivo Bioscience
Compare insights from companies similar to Zivo Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zivo Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Zivo Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Zivo Bioscience.
Zivo Bioscience financials insights
Gather financial insights about Zivo Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$17.5M
Zivo Bioscience Tech Stack
A closer look at the technologies used by Zivo Bioscience
Most Recent Scoops
Zivo Bioscience News & Media
ZIVO Bioscience to Present at The Microcap Conference 2025
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced its participation in The Microcap Conference 2025 being held January 28-30, 2025, in Atlantic City, N.J. Management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to diZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today provided an update on activities related to licensing its product targeting coccidiosis in broiler chickens. Following the announcement in August 2024 of positive results from a 42-day coccidiosis study, the Company has been engaged in discussionsZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, reports favorable results from a study conducted in collaboration with the University of Delaware that evaluated the potential of ZIVO’s proprietary active ingredients to reduce the transmission of Low Pathogenicity Avian Influenza (LPAI) virus among poZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, reports favorable results from its latest 42-day study with its product targeting coccidiosis in broiler chickens. The study, which was conducted in collaboration with a major global animal health company and replicated real-world poultry production env
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Zivo Bioscience
Zivo Bioscience, Inc. is a U.S.-based research and development firm focused on the study, development, and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. The company offers algae-based products for both animal and human applications, promoting health benefits such as improved immun... Read More